vs
Side-by-side financial comparison of BILL Holdings, Inc. (BILL) and Bio-Techne (TECH). Click either name above to swap in a different company.
BILL Holdings, Inc. is the larger business by last-quarter revenue ($414.7M vs $295.9M, roughly 1.4× Bio-Techne). Bio-Techne runs the higher net margin — 12.8% vs -0.6%, a 13.5% gap on every dollar of revenue. On growth, BILL Holdings, Inc. posted the faster year-over-year revenue change (14.4% vs -6.4%). Over the past eight quarters, BILL Holdings, Inc.'s revenue compounded faster (13.3% CAGR vs 4.2%).
BILL Holdings, Inc. is an American company based in San Jose, California, that provides automated, cloud-based software for financial operations for small businesses in the United States. A white-labeled, end-to-end payments automation platform, Bill.com Connect is offered to financial institutions as part of their single sign-on online business banking ecosystem.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
BILL vs TECH — Head-to-Head
Income Statement — Q2 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $414.7M | $295.9M |
| Net Profit | $-2.6M | $38.0M |
| Gross Margin | 79.8% | 64.6% |
| Operating Margin | -4.4% | 18.4% |
| Net Margin | -0.6% | 12.8% |
| Revenue YoY | 14.4% | -6.4% |
| Net Profit YoY | -107.7% | 68.3% |
| EPS (diluted) | $-0.03 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $414.7M | $295.9M | ||
| Q3 25 | $395.7M | — | ||
| Q2 25 | $383.3M | $317.0M | ||
| Q1 25 | $358.2M | $316.2M | ||
| Q4 24 | $362.6M | $297.0M | ||
| Q3 24 | $358.4M | $289.5M | ||
| Q2 24 | $343.7M | $306.1M | ||
| Q1 24 | $323.0M | $303.4M |
| Q4 25 | $-2.6M | $38.0M | ||
| Q3 25 | $-3.0M | — | ||
| Q2 25 | $-7.1M | $-17.7M | ||
| Q1 25 | $-11.6M | $22.6M | ||
| Q4 24 | $33.5M | $34.9M | ||
| Q3 24 | $8.9M | $33.6M | ||
| Q2 24 | $7.6M | $40.6M | ||
| Q1 24 | $31.8M | $49.1M |
| Q4 25 | 79.8% | 64.6% | ||
| Q3 25 | 80.5% | — | ||
| Q2 25 | 80.8% | 62.7% | ||
| Q1 25 | 81.2% | 67.9% | ||
| Q4 24 | 81.6% | 65.3% | ||
| Q3 24 | 82.0% | 63.2% | ||
| Q2 24 | 81.0% | 66.4% | ||
| Q1 24 | 83.0% | 67.4% |
| Q4 25 | -4.4% | 18.4% | ||
| Q3 25 | -5.2% | — | ||
| Q2 25 | -5.8% | -7.5% | ||
| Q1 25 | -8.1% | 12.2% | ||
| Q4 24 | -6.0% | 16.0% | ||
| Q3 24 | -2.1% | 13.8% | ||
| Q2 24 | -6.5% | 15.0% | ||
| Q1 24 | -8.6% | 22.1% |
| Q4 25 | -0.6% | 12.8% | ||
| Q3 25 | -0.7% | — | ||
| Q2 25 | -1.8% | -5.6% | ||
| Q1 25 | -3.2% | 7.1% | ||
| Q4 24 | 9.3% | 11.7% | ||
| Q3 24 | 2.5% | 11.6% | ||
| Q2 24 | 2.2% | 13.3% | ||
| Q1 24 | 9.8% | 16.2% |
| Q4 25 | $-0.03 | $0.24 | ||
| Q3 25 | $-0.03 | — | ||
| Q2 25 | $0.02 | $-0.11 | ||
| Q1 25 | $-0.11 | $0.14 | ||
| Q4 24 | $-0.06 | $0.22 | ||
| Q3 24 | $0.08 | $0.21 | ||
| Q2 24 | $0.37 | $0.26 | ||
| Q1 24 | $0.00 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.1B | $172.9M |
| Total DebtLower is stronger | $1.8B | $260.0M |
| Stockholders' EquityBook value | $3.8B | $2.0B |
| Total Assets | $10.1B | $2.5B |
| Debt / EquityLower = less leverage | 0.48× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.1B | $172.9M | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $1.0B | $162.2M | ||
| Q1 25 | $1.0B | $140.7M | ||
| Q4 24 | $1.6B | $177.5M | ||
| Q3 24 | $853.5M | $187.5M | ||
| Q2 24 | $985.9M | $152.9M | ||
| Q1 24 | $952.5M | $145.3M |
| Q4 25 | $1.8B | $260.0M | ||
| Q3 25 | $1.9B | — | ||
| Q2 25 | $1.7B | $346.0M | ||
| Q1 25 | $1.7B | $330.0M | ||
| Q4 24 | $1.7B | $300.0M | ||
| Q3 24 | $914.8M | $300.0M | ||
| Q2 24 | $914.0M | $319.0M | ||
| Q1 24 | $1.1B | $389.0M |
| Q4 25 | $3.8B | $2.0B | ||
| Q3 25 | $3.9B | — | ||
| Q2 25 | $3.9B | $1.9B | ||
| Q1 25 | $3.9B | $2.0B | ||
| Q4 24 | $3.8B | $2.1B | ||
| Q3 24 | $4.0B | $2.1B | ||
| Q2 24 | $4.1B | $2.1B | ||
| Q1 24 | $4.1B | $2.0B |
| Q4 25 | $10.1B | $2.5B | ||
| Q3 25 | $10.2B | — | ||
| Q2 25 | $10.1B | $2.6B | ||
| Q1 25 | $9.6B | $2.6B | ||
| Q4 24 | $9.7B | $2.7B | ||
| Q3 24 | $9.0B | $2.7B | ||
| Q2 24 | $9.2B | $2.7B | ||
| Q1 24 | $9.1B | $2.7B |
| Q4 25 | 0.48× | 0.13× | ||
| Q3 25 | 0.48× | — | ||
| Q2 25 | 0.44× | 0.18× | ||
| Q1 25 | 0.43× | 0.16× | ||
| Q4 24 | 0.44× | 0.14× | ||
| Q3 24 | 0.23× | 0.14× | ||
| Q2 24 | 0.22× | 0.15× | ||
| Q1 24 | 0.28× | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $105.3M | — |
| Free Cash FlowOCF − Capex | $103.8M | — |
| FCF MarginFCF / Revenue | 25.0% | — |
| Capex IntensityCapex / Revenue | 0.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $378.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $105.3M | — | ||
| Q3 25 | $96.9M | — | ||
| Q2 25 | $83.8M | $98.2M | ||
| Q1 25 | $99.5M | $41.1M | ||
| Q4 24 | $78.7M | $84.3M | ||
| Q3 24 | $88.6M | $63.9M | ||
| Q2 24 | $78.6M | $75.5M | ||
| Q1 24 | $66.8M | $81.0M |
| Q4 25 | $103.8M | — | ||
| Q3 25 | $95.6M | — | ||
| Q2 25 | $81.0M | $93.3M | ||
| Q1 25 | $98.4M | $31.0M | ||
| Q4 24 | $78.3M | $77.5M | ||
| Q3 24 | $88.6M | $54.7M | ||
| Q2 24 | $78.4M | $57.5M | ||
| Q1 24 | $66.8M | $64.5M |
| Q4 25 | 25.0% | — | ||
| Q3 25 | 24.1% | — | ||
| Q2 25 | 21.1% | 29.4% | ||
| Q1 25 | 27.5% | 9.8% | ||
| Q4 24 | 21.6% | 26.1% | ||
| Q3 24 | 24.7% | 18.9% | ||
| Q2 24 | 22.8% | 18.8% | ||
| Q1 24 | 20.7% | 21.3% |
| Q4 25 | 0.4% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.7% | 1.5% | ||
| Q1 25 | 0.3% | 3.2% | ||
| Q4 24 | 0.1% | 2.3% | ||
| Q3 24 | 0.0% | 3.2% | ||
| Q2 24 | 0.1% | 5.9% | ||
| Q1 24 | 0.0% | 5.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | 2.35× | 2.42× | ||
| Q3 24 | 9.94× | 1.90× | ||
| Q2 24 | 10.35× | 1.86× | ||
| Q1 24 | 2.10× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BILL
| Accounts Payable And Accounts Receivable Solutions | $185.9M | 45% |
| Spend And Expense Interchange Revenue | $166.5M | 40% |
| Interest On Funds Held For Customers | $39.5M | 10% |
| Embedded And Other Solutions | $22.8M | 5% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
